PMED — Predictmedix AI Share Price
- CA$6.76m
- CA$6.72m
- CA$0.04m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 64.26 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1,432.56 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -2423.62% | ||
Return on Equity | -1170.18% | ||
Operating Margin | -53915.25% |
Financial Summary
Year End 31st Jan | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | n/a | n/a | n/a | 0.13 | 0.04 | n/a | n/a | -60.05% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Predictmedix AI Inc. is a Canada-based provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations, powered by artificial intelligence AI, use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including infectious diseases, such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses. Its remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. Its solutions include Infectious Disease Screening, Impairment Screening, and Mobilewellbeing. The Infectious Disease Screening screen for COVID-19, its variants, and other infectious diseases. It offers cannabis and alcohol impairment screening. Mobilewellbeing is a software platform with patient monitoring devices. The Company’s autonomous, non-invasive, no-contact solutions detect symptoms before they spread through workplace.
Directors
- Sheldon Kales PRE (55)
- Rakesh Malhotra CFO (61)
- Rahul Kushwah COO
- Lucas Zimmerman OTH
- Ajit Kumar IND
- Tomas Sipos IND
- Last Annual
- January 31st, 2023
- Last Interim
- October 31st, 2023
- Incorporated
- September 3rd, 1987
- Public Since
- December 20th, 2019
- No. of Employees
- 3
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 150,259,542
- Address
- 3000 - 77 King Street West, TORONTO, M5K 1G8
- Web
- https://predictmedix.com/
- Phone
- +1 6478896916
- Contact
- Lucas Zimmerman
- Auditors
- Kreston GTA LLP
Upcoming Events for PMED
Q1 2024 Predictmedix AI Inc Earnings Release
Similar to PMED
Abound Energy
Canadian Securities Exchange
American Aires
Canadian Securities Exchange
Beyond Oil
Canadian Securities Exchange
Hybrid Power Solutions
Canadian Securities Exchange
Li-Metal
Canadian Securities Exchange
FAQ
As of Today at 18:17 UTC, shares in Predictmedix AI are trading at CA$0.05. This share price information is delayed by 15 minutes.
Shares in Predictmedix AI last closed at CA$0.05 and the price had moved by -64% over the past 365 days. In terms of relative price strength the Predictmedix AI share price has underperformed the Toronto Stock Exchange 300 Composite Index by -68.07% over the past year.
There is no consensus recommendation for this security.
Predictmedix AI does not currently pay a dividend.
Predictmedix AI does not currently pay a dividend.
Predictmedix AI does not currently pay a dividend.
To buy shares in Predictmedix AI you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.05, shares in Predictmedix AI had a market capitalisation of CA$6.76m.
Here are the trading details for Predictmedix AI:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: PMED
Based on an overall assessment of its quality, value and momentum Predictmedix AI is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Predictmedix AI. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -52.32%.
As of the last closing price of CA$0.05, shares in Predictmedix AI were trading -42.34% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Predictmedix AI PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Predictmedix AI's management team is headed by:
- Sheldon Kales - PRE
- Rakesh Malhotra - CFO
- Rahul Kushwah - COO
- Lucas Zimmerman - OTH
- Ajit Kumar - IND
- Tomas Sipos - IND